biopharmapatent

Thursday, February 9, 2017

The Federal Circuit Stays Injunction in Sanofi/Amgen Patent Fight over PCSK9 Inhibitor

http://bit.ly/2kAA3bP
Posted by Paul Moradian's Pharma blog at 10:58 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

LinkedIn

Blog Archive

  • ►  2020 (2)
    • ►  August (1)
    • ►  April (1)
  • ►  2019 (5)
    • ►  January (5)
  • ►  2018 (4)
    • ►  December (1)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
  • ▼  2017 (63)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  August (5)
    • ►  July (9)
    • ►  June (4)
    • ►  May (10)
    • ►  April (4)
    • ►  March (13)
    • ▼  February (7)
      • GENENTECH’S PATENT TO A METHOD FOR INCREASING YIEL...
      • Dr. Reddy’s Infringes Aloxi (palonosetron) Patents
      • PTAB Grants Petition for Inter Partes Review of Am...
      • GENENTECH: AMGEN NOT DISCLOSING MANUFACTURING PROC...
      • COHERUS FILES FOUR IPR PETITIONS AGAINST HUMIRA BU...
      • The Federal Circuit Stays Injunction in Sanofi/Amg...
      • HOSPIRA'S NEW HERCEPTIN IPRS (INTER PARTES REVIEW)
    • ►  January (5)
  • ►  2016 (23)
    • ►  December (5)
    • ►  November (6)
    • ►  October (3)
    • ►  September (9)

About Me

Paul Moradian's Pharma blog
View my complete profile
Payam Moradian's blog. Simple theme. Powered by Blogger.